HK1006279A1 - Topical composition - Google Patents

Topical composition

Info

Publication number
HK1006279A1
HK1006279A1 HK98105449A HK98105449A HK1006279A1 HK 1006279 A1 HK1006279 A1 HK 1006279A1 HK 98105449 A HK98105449 A HK 98105449A HK 98105449 A HK98105449 A HK 98105449A HK 1006279 A1 HK1006279 A1 HK 1006279A1
Authority
HK
Hong Kong
Prior art keywords
topical composition
liquid phases
application
human
intended
Prior art date
Application number
HK98105449A
Other languages
English (en)
Inventor
Adrian Francis Davis
Jennifer Jane Gordon
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of HK1006279A1 publication Critical patent/HK1006279A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK98105449A 1990-11-27 1998-06-16 Topical composition HK1006279A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909025711A GB9025711D0 (en) 1990-11-27 1990-11-27 Topical composition
PCT/GB1991/002064 WO1992009266A1 (en) 1990-11-27 1991-11-21 Topical composition

Publications (1)

Publication Number Publication Date
HK1006279A1 true HK1006279A1 (en) 1999-02-19

Family

ID=10686018

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98105449A HK1006279A1 (en) 1990-11-27 1998-06-16 Topical composition

Country Status (19)

Country Link
EP (1) EP0559682B1 (es)
JP (1) JPH06502856A (es)
KR (1) KR100218652B1 (es)
AT (1) ATE128862T1 (es)
AU (1) AU661283B2 (es)
CA (1) CA2096963C (es)
DE (1) DE69113811T2 (es)
DK (1) DK0559682T3 (es)
ES (1) ES2079687T3 (es)
GB (1) GB9025711D0 (es)
GR (1) GR3018613T3 (es)
HK (1) HK1006279A1 (es)
IE (1) IE68953B1 (es)
MY (1) MY108692A (es)
NZ (1) NZ240707A (es)
PT (1) PT99608B (es)
SA (1) SA92120308B1 (es)
WO (1) WO1992009266A1 (es)
ZA (1) ZA919289B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9125712D0 (en) * 1991-12-03 1992-01-29 Smithkline Beecham Plc Skin care composition
GB9207988D0 (en) * 1992-04-10 1992-05-27 Smithkline Beecham Plc Topical composition
US5464610A (en) * 1992-10-15 1995-11-07 Schering-Plough Healthcare Products, Inc. Method for treating onychomycosis
US5484606A (en) * 1994-01-24 1996-01-16 The Procter & Gamble Company Process for reducing the precipitation of difficulty soluble pharmaceutical actives
US6019988A (en) * 1996-11-18 2000-02-01 Bristol-Myers Squibb Company Methods and compositions for enhancing skin permeation of drugs using permeation enhancers, when drugs and/or permeation enhancers are unstable in combination during long-term storage
FR2771634B1 (fr) * 1997-12-02 2000-04-28 Jean Pierre Benoit Produit d'hygiene capillaire et/ou corporelle pour les hommes et les animaux et procede pour sa fabrication
US6649174B2 (en) * 1998-05-07 2003-11-18 E-L Management Corp. Dual phase cosmetic composition
US6524623B1 (en) * 1999-11-12 2003-02-25 Milton Hodosh Therapeutic compositions and methods of use thereof
DE10235422A1 (de) * 2002-08-02 2004-02-12 Beiersdorf Ag Kosmetische Zubereitungen mit zwei Phasen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8319540D0 (en) * 1983-07-20 1983-08-24 Bovril Ltd Amine removal
GB8629639D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
GB8401965D0 (en) * 1984-01-25 1984-02-29 Beecham Group Plc Composition

Also Published As

Publication number Publication date
IE914090A1 (en) 1992-06-03
ES2079687T3 (es) 1996-01-16
DE69113811D1 (de) 1995-11-16
WO1992009266A1 (en) 1992-06-11
JPH06502856A (ja) 1994-03-31
KR100218652B1 (ko) 1999-09-01
CA2096963C (en) 2002-04-30
MY108692A (en) 1996-10-31
PT99608B (pt) 1999-05-31
KR930702958A (ko) 1993-11-29
EP0559682B1 (en) 1995-10-11
GB9025711D0 (en) 1991-01-09
NZ240707A (en) 1994-02-25
AU8929591A (en) 1992-06-25
ATE128862T1 (de) 1995-10-15
DK0559682T3 (da) 1995-12-04
SA92120308B1 (ar) 2005-06-15
AU661283B2 (en) 1995-07-20
EP0559682A1 (en) 1993-09-15
GR3018613T3 (en) 1996-04-30
DE69113811T2 (de) 1996-04-11
ZA919289B (en) 1992-10-28
CA2096963A1 (en) 1992-05-28
PT99608A (pt) 1992-11-30
IE68953B1 (en) 1996-07-24

Similar Documents

Publication Publication Date Title
MX9305146A (es) Conjugado de interferon, procedimiento para su preracion y composicion farmaceutica que lo contienen.
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
ZA91353B (en) Pharmaceutical and cosmetic compositions
HU9600162D0 (en) Use of an antagonist of cgrp in cosmetic, pharmaceutical or dermatological composition and the cosmetic compositions
DE69014351D1 (de) Pyridincarbonsäureamid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
SE8702642L (sv) Lokalt anvendbara, farmaceutiska beredningar
IL133784A (en) Dolastatin 15 derivatives, pharmaceutical compositions comprising them and their use in medicaments for treating cancer
DE69301356T2 (de) Übersättigte topische zusammensetzungen
ZA919289B (en) Topical composition
EE04493B1 (et) Tsüklopenteeni derivaadid, neid sisaldav farmatseutiline kompositsioon ning ühendite kasutamine ravimina inimestel esinevate motiliini retseptoriga seotud häirete raviks
DK0416678T3 (da) Topiske præparater indeholdende Defibrotid
GB9504040D0 (en) Arylsulfonamide derivative and pharmaceutical composition containing the same
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
EP0391852A3 (en) Pharmaceutical compositions
MX9100886A (es) Activador de plasminogeno hibrido,procedimiento para su preparacion y composiciones farmaceuticas que lo contienen
AU2742395A (en) Therapeutic or dietetic composition in the form of medicinal gel for the administration to pets
EP0190860A3 (en) 6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it
HUP9903375A2 (hu) Olanzapint és fájdalomcsillapító hatóanyagot tartalmazó szinergista hatású gyógyszerkészítmények
FI954982A (fi) Uusia naftyridiinijohdannaisia, menetelmiä niiden valmistamiseksi sekä niitä sisältäviä farmaseuttisia koostumuksia käytettäväksi erityisesti solujen lisääntymistä estävinä lääkkeinä
ZA944187B (en) Ipsapirone medicament formulation
ZA944103B (en) Dosage form for administering drug in liquid formulation
IL105296A0 (en) Pharmaceutical formulation for topical application in the treatment of dry skin
IL103676A0 (en) Pharmaceutical compositions containing hemoglobins as drug delivery agents and methods for the preparation thereof
ZW10790A1 (en) Drug for use in pharmaceutical compositions
EE9700021A (et) Fibriinile mõju avaldav monoklooniline antikeha kasutamiseks tromboosivastases ravis, farmatseutilised kompositsioonid ja ravimaine

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20101121